How to appeal a Cigna glp-1 weight-loss drugs denial

The framework that applies to your appeal

Federal law gives you the right to a full and fair internal appeal, then an external review by an independent third party.

Cigna-specific note: Sold its Medicaid Advantage book to HCSC in 2023. Express Scripts (PBM) is Cigna-owned. Frequent class-action litigation around mental health parity.

What Cigna's policy requires for glp-1 weight-loss drugs

Cited policy: coverage policy: Weight Loss Medications

BMI >=30, OR BMI >=27 with comorbidity. 6-month lifestyle modification documented. Continuation requires >=5% weight loss at 6 months.

How Cigna denies glp-1 weight-loss drugs — and how to counter it

Where Cigna pushes back: 1) BMI below 27; 2) No documented 6-month lifestyle attempt; 3) Continuation denied due to insufficient loss at 6 months.

Counter-arguments that hold up: Sub-27 with severe comorbidity: ABCD (AACE 2023) supports pharmacotherapy for BMI 25-27 with severe complications. Lifestyle: WW, Noom, Optavia, Profile, physician-supervised programs all qualify. Continuation <5%: argue HbA1c improvement, BP, waist circumference, AHI reductions.

What Cigna typically denies for glp-1 weight-loss drugs

Across Cigna's commercial and Medicare books, denials cluster around a small number of patterns. For glp-1 weight-loss drugs, expect:

• Mental health parity violations
• Step therapy
• Specialty drug prior auth
• OON balance billing disputes

Treatments most often denied in this category

These are the glp-1 weight-loss drugs treatments most often flagged for prior auth, step therapy, or medical necessity review:

• Wegovy
• Zepbound
• Mounjaro
• Ozempic
• Saxenda
• PHENTERMINE AND TOPIRAMATE

How to submit the appeal to Cigna

1. Read the denial letter — note the exact denial reason code and the appeal deadline (180 days from the date on the letter).
2. Gather supporting documentation: physician letter of medical necessity, relevant clinical notes, peer-reviewed citations supporting the treatment for your indication, and the policy or coverage document Cigna cited in the denial.
3. File the appeal through Cigna's portal (members: https://my.cigna.com ; providers: https://cignaforhcp.cigna.com). Standard decision returns within 30 days; expedited urgent appeals return within 72 hours.
4. If denied again, request external review by an independent reviewer within 4 months of the final internal denial. In CT, the state insurance department coordinates external review for fully-insured plans; ERISA self-funded plans use a federal external review through DOL/EBSA.

Clinician or prior-auth team handling this on the practice side? See Cigna's prior-authorization criteria by drug: Cigna PA criteria on ApprovalHelp.